Pivotal Study to Evaluate the Safety and Efficacy of GelrinC for Treatment of Cartilage Defects
Clinical trial NCT03262909 · UNKNOWN
Trial details
- NCT number
- NCT03262909
- Sponsor
- Regentis Biomaterials
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-14
- Primary completion
- 2023-04-01
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.